CHRISTINE COLLINS: Open Payments
NPI 1689018731 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,333 in 196 payments from 21 companies in 2025. Trend: 2023 $2,433 · 2024 $3,276 · 2025 $3,333
Food & beverage: $3,142Education: $191
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 38 | $662 |
| Amgen Inc. | 42 | $620 |
| ABBVIE INC. | 37 | $594 |
| UCB, Inc. | 13 | $234 |
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| GlaxoSmithKline, LLC. | 11 | $179 |
| E.R. Squibb & Sons, L.L.C. | 9 | $147 |
| Organon LLC | 9 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| PFIZER INC. | 4 | $77 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, SAPHNELO, BENLYSTA, KRYSTEXXA, OTEZLA.
Industry payments across PA — which companies pay providers there.
